Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KREMEN2 |
| Upstream (Parents) |
|---|
| (<<) ANKRD57 → KREMEN2 |
| (<<) ANTXR1 → KREMEN2 |
| (<<) CTPS → KREMEN2 |
| (<<) E2F5 → KREMEN2 |
| (<<) FZD2 → KREMEN2 |
| (<<) GRN → KREMEN2 |
| (<<) HSPA8 → KREMEN2 |
| (<<) LTA4H → KREMEN2 |
| (<<) PSTPIP1 → KREMEN2 |
| (<<) SMTN → KREMEN2 |
| (<<) STK4 → KREMEN2 |
| (<<) TRIM32 → KREMEN2 |
| Downstream (Children) |
|---|
| KREMEN2 → AREG (>>) |
| KREMEN2 → BCAR3 (>>) |
| KREMEN2 → CREBBP (>>) |
| KREMEN2 → EGFR (>>) |
| KREMEN2 → JAG1 (>>) |
| KREMEN2 → KRT1 (>>) |
| KREMEN2 → MYL3 (>>) |
| KREMEN2 → SPATA2L (>>) |
